A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
Clinical trial NCT03086343 · COMPLETED
Trial details
- NCT number
- NCT03086343
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2019-06-13
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.